Evidence map›Paper›PMID 38701160›Full record

ArticleJournal of Parkinson's disease2024

Oculomotor Dysfunction in Idiopathic and LRRK2-Parkinson's Disease and At-Risk Individuals.

Carmen Lage, Antonio Sánchez-Rodríguez, María Rivera-Sánchez, María Sierra, Isabel González-Aramburu, Jorge Madera, Manuel Delgado-Alvarado, Sara López-García, Francisco Martínez-Dubarbie, Marta Fernández-Matarrubia and 7 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Carmen LageNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Antonio Sánchez-RodríguezInstitute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
María Rivera-SánchezNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
María SierraNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Isabel González-AramburuNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Jorge MaderaNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Manuel Delgado-AlvaradoInstitute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
Sara López-GarcíaNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Francisco Martínez-DubarbieNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Marta Fernández-MatarrubiaNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Néstor Martínez-AmadorInstitute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
Isabel Martínez-RodríguezInstitute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
Alberto Calvo-CórdobaCentre for Automation and Robotics, Escuela Técnica de Ingenieros Industriales (ETSII), Universidad Politécnica de Madrid, Madrid, Spain.
Eloy Rodríguez-RodríguezNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.
Cecilia García-CenaCentre for Automation and Robotics, UPM-CSIC, Escuela Técnica Superiorde Ingeniería y Diseño Industrial, Universidad Politécnica de Madrid, Madrid, Spain.
Pascual Sánchez-JuanInstitute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.
Jon InfanteNeurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Video-oculography constitutes a highly-sensitive method of characterizing ocular movements, which could detect subtle premotor changes and contribute to the early diagnosis of Parkinson's disease (PD). Objective: To investigate potential oculomotor differences between idiopathic PD (iPD) and PD associated with the G2019S variant of LRRK2 (L2PD), as well as to evaluate oculomotor function in asymptomatic carriers of the G2019S variant of LRRK2. Methods: The study enrolled 129 subjects: 30 PD (16 iPD, 14 L2PD), 23 asymptomatic carriers, 13 non-carrier relatives of L2PD patients, and 63 unrelated HCs. The video-oculographic evaluation included fixation, prosaccade, antisaccade, and memory saccade tests. Results: We did not find significant differences between iPD and L2PD. Compared to controls, PD patients displayed widespread oculomotor deficits including larger microsaccades, hypometric vertical prosaccades, increased latencies in all tests, and lower percentages of successful antisaccades and memory saccades. Non-carrier relatives showed oculomotor changes with parkinsonian features, such as fixation instability and hypometric vertical saccades. Asymptomatic carriers shared multiple similarities with PD, including signs of unstable fixation and hypometric vertical prosaccades; however, they were able to reach percentages of successful antisaccade and memory saccades similar to controls, although at the expense of longer latencies. Classification accuracy of significant oculomotor parameters to differentiate asymptomatic carriers from HCs ranged from 0.68 to 0.74, with BCEA, a marker of global fixation instability, being the parameter with the greatest classification accuracy. Conclusions: iPD and LRRK2-G2019S PD patients do not seem to display a differential oculomotor profile. Several oculomotor changes in asymptomatic carriers of LRRK2 mutations could be considered premotor biomarkers.

Indexed as

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseAdultAgedFemaleHeterozygoteHumansMaleMiddle AgedOcular Motility DisordersSaccadesLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanantisaccadeearly diagnosiseye-trackingLRRK2microsaccadeoculomotorParkinson’s diseasepremotor

Identifiers

PMID38701160
PMCPMC11191487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.